Doctors split on Avastin for breast cancer: survey – Reuters


Fox News
Doctors split on Avastin for breast cancer: survey
Reuters
NEW YORK (Reuters Health) – An international survey of cancer doctors shows that many question health advisers' 2010 rejection of Roche Holding's drug Avastin to treat advanced breast cancer. The small survey, published in the
Doctors Split on Avastin for Breast Cancer, Survey SaysFox News
Avastin Rejection By FDA To Treat Advanced Breast Cancer Questioned By DoctorsThirdAge
Avastin (bevacizumab) – Many Doctors Disagree With FDA RulingMedical News Today
FiercePharma
all 157 news articles »